Exchange: NASDAQ·Updated 11:33 AM EDT
CING logo

CING Cingulate Inc

$5.09
$0.24
(4.51%)
Today
Mkt Cap$77.44M
Vol130,325.00

About CING

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in May 2012 and is headquartered in Kansas City, KS.
69

Bullish Sentiment

How do you feel about CING?

Advertisement|Remove ads.